McKesson (MCK) Stock Forecast & Price Target

$600.16

+4.43 (+0.74%)

(As of 07/26/2024 ET)

McKesson - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Moderate Buy
Based on 16 Analyst Ratings

Based on 16 Wall Street analysts who have issued ratings for McKesson in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 16 analysts, 2 have given a hold rating, and 14 have given a buy rating for MCK.

Consensus Price Target

$599.33
-0.14% Downside

High Forecast	$694.00
Average Forecast	$599.33
Low Forecast	$485.00

According to the 16 analysts' twelve-month price targets for McKesson, the average price target is $599.33. The highest price target for MCK is $694.00, while the lowest price target for MCK is $485.00. The average price target represents a forecasted downside of -0.14% from the current price of $600.16.

Type	Current Forecast 7/27/23 to 7/26/24	1 Month Ago 6/27/23 to 6/26/24	3 Months Ago 4/28/23 to 4/27/24	1 Year Ago 7/27/22 to 7/27/23
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy	Moderate Buy
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	14 Buy rating(s)	14 Buy rating(s)	10 Buy rating(s)	6 Buy rating(s)
Hold	2 Hold rating(s)	2 Hold rating(s)	2 Hold rating(s)	2 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$599.33	$590.47	$533.50	$436.17
Forecasted Upside	-0.14% Downside	10.55% Upside	11.27% Upside	15.86% Upside

Get McKesson Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for MCK and its competitors with MarketBeat's FREE daily newsletter.

Ad Porter & Company

Obama wins Presidential debate

When I said Obama would seek a third term… They called me a conspiracy theorist, they said it couldn’t happen, that the 22nd Amendment makes it impossible. But as I explained on live radio years ago, “he could have a proxy… while he remains in control of the administration much like Putin did in Russia.”

Please, watch this now before it’s too late.

MCK Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

MCK Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

McKesson Stock vs. The Competition

Type	McKesson	Medical Companies	S&P 500
Consensus Rating Score	2.88	2.72	2.50
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy
Predicted Upside	-0.14% Downside	3,123.18% Upside	9.15% Upside
News Sentiment Rating	Positive News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
7/19/2024	Citigroup 3 of 5 stars		Boost Target	Buy ➝ Buy	$620.00 ➝ $670.00	+15.32%
7/9/2024	Evercore ISI 2 of 5 stars		Boost Target	Outperform ➝ Outperform	$600.00 ➝ $660.00	+11.96%
7/9/2024	Robert W. Baird 2 of 5 stars		Boost Target	Outperform ➝ Outperform	$679.00 ➝ $694.00	+17.74%
6/25/2024	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$590.00 ➝ $670.00	+10.23%
6/24/2024	Argus Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$570.00 ➝ $670.00	+11.10%
5/9/2024	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Buy ➝ Buy	$547.00 ➝ $545.00	-1.45%
Get the Latest News and Ratings for MCK and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for McKesson and its competitors with MarketBeat's FREE daily newsletter.
5/9/2024	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Equal Weight ➝ Equal Weight	$502.00 ➝ $551.00	-0.41%
5/8/2024	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Overweight ➝ Overweight	$571.00 ➝ $596.00	+10.28%
5/8/2024	TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$563.00 ➝ $652.00	+19.74%
5/8/2024	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$620.00 ➝ $630.00	+14.00%
4/15/2024	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Overweight ➝ Overweight	$522.00 ➝ $548.00	+4.21%
2/26/2024	Leerink Partnrs Subscribe to MarketBeat All Access for the recommendation accuracy rating	M. Cherny Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Outperform
2/26/2024	SVB Leerink Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Outperform	$600.00	+16.23%
2/9/2024	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Neutral ➝ Neutral	$450.00 ➝ $505.00	+0.48%
11/17/2023	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Overweight ➝ Overweight	$495.00 ➝ $514.00	+14.04%
8/11/2023	Credit Suisse Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Outperform ➝ Outperform	$450.00 ➝ $485.00	+11.71%
5/9/2023	58.com Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Maintains
11/2/2022	Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target		$384.00 ➝ $416.00	+5.96%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Friday at 10:17 PM ET.

MCK Forecast - Frequently Asked Questions

What is McKesson's forecast for 2024?: According to the research reports of 16 Wall Street equities research analysts, the average twelve-month stock price forecast for McKesson is $599.33, with a high forecast of $694.00 and a low forecast of $485.00.
Should I buy or sell McKesson stock right now?: 16 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for McKesson in the last year. There are currently 2 hold ratings and 14 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" MCK shares.
Does McKesson's stock price have much upside?: According to analysts, McKesson's stock has a predicted upside of 10.38% based on their 12-month stock forecasts.
What analysts cover McKesson?: McKesson has been rated by research analysts at Argus, Bank of America, Barclays, Citigroup, Deutsche Bank Aktiengesellschaft, Evercore ISI, Robert W. Baird, TD Cowen, UBS Group, and Wells Fargo & Company in the past 90 days.
Do Wall Street analysts like McKesson more than its competitors?: Analysts like McKesson more than other "medical" companies. The consensus rating score for McKesson is 2.88 while the average consensus rating score for "medical" companies is 2.72. Learn more on how MCK compares to other companies.